Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss
Medtronic Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss decreased by 30.0% to $7.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 22.2%, from $9.00M to $7.00M. Over 4 years (FY 2021 to FY 2025), Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss shows relatively stable performance with a -2.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase suggests recent market headwinds impacting the valuation of the fixed-income portfolio.
Detailed definition
The cumulative amount of unrealized losses for debt securities that have been in a continuous loss position for less tha...
Peer comparison
Standard disclosure for insurance companies to track the aging of unrealized losses.
other_debt_securities_available_for_sale_continuous_unre_d33b47Historical Data
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.00M | $6.00M | $0.00 | $0.00 | $1.00M | $2.00M | $4.00M | $7.00M | $8.00M | $9.00M | $10.00M | $9.00M | $14.00M | $12.00M | $10.00M | $9.00M | $9.00M | $9.00M | $10.00M | $7.00M |
| QoQ Change | — | -40.0% | -100.0% | — | — | +100.0% | +100.0% | +75.0% | +14.3% | +12.5% | +11.1% | -10.0% | +55.6% | -14.3% | -16.7% | -10.0% | +0.0% | +0.0% | +11.1% | -30.0% |
| YoY Change | — | — | — | — | -90.0% | -66.7% | — | — | +700.0% | +350.0% | +150.0% | +28.6% | +75.0% | +33.3% | +0.0% | +0.0% | -35.7% | -25.0% | +0.0% | -22.2% |
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss at Other Companies
Frequently Asked Questions
- What is Medtronic's debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss?
- Medtronic (MDT) reported debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss of $7.00M in Q4 2025.
- How has Medtronic's debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss changed year-over-year?
- Medtronic's debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss decreased by 22.2% year-over-year, from $9.00M to $7.00M.
- What is the long-term trend for Medtronic's debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss?
- Over 4 years (2021 to 2025), Medtronic's debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss has grown at a -2.6% compound annual growth rate (CAGR), from $10.00M to $9.00M.
- What does debt securities, available-for-sale, continuous unrealized loss position, less than 12 months, accumulated loss mean?
- The total dollar amount of paper losses on debt securities that have been losing value for less than a year.